-37%

est. 2Y upside i

HealthcareAI & MLSeries B

Sennos revolutionizes fluid monitoring with real-time, IoT-enabled solutions that transform production quality and profitability.

Rank

#974

Sector

Industrial Biotechnology, Artificial Intelligence, Industrial Automation

Est. Liquidity

~3Y

Data Quality

Data: Medium

Sennos presents a moderate upside opportunity for a job seeker.

Last updated: March 10, 2026

Bull (30%)+250%

Sennos successfully expands its AI-driven platform beyond brewing into high-growth segments like precision fermentation for alternative proteins and pharmaceuticals, leveraging its proprietary data and full-stack ownership. Strong adoption of the SennosM3 and recurring software subscriptions drive revenue to $50M+ by 2028, justifying a $280M+ valuation (3.5x current) as a leader in a critical niche.

Base (50%)+50%

Sennos maintains its strong position in the brewing and beverage industry while making steady inroads into adjacent markets. Revenue grows consistently at ~25-30% YoY, reaching $25M-$30M by 2028, leading to an acquisition or later-stage funding round at a $120M valuation (1.5x current), reflecting solid execution and market fit.

Bear (20%)-60%

Despite a strong moat, larger industrial automation or biotech incumbents introduce competitive, integrated solutions, or market adoption in new segments is slower than anticipated due to high regulatory barriers. Growth stalls, leading to a down round or acquisition at a distressed valuation of $32M (0.4x current), significantly eroding common stock value given the preference stack.

Est. time to liquidity~3.0 years

Preference Stack Risk

high

Investors hold $20M in liquidation preferences ahead of common shareholders, representing 25% of the estimated $80M valuation.

Dilution Risk

moderate

As a Series B company, Sennos will likely require at least one to two more funding rounds, leading to further dilution for existing common shareholders.

Secondary Liquidity

none

There is no indication of active secondary markets or tender offers for Sennos equity at this stage.

Questions to Ask at the Interview

Strategic questions based on Sennos's data — designed to show you've done your homework.

  • 1

    “Given the high regulatory barriers in pharmaceuticals and biomanufacturing, what specific strategies are in place to accelerate compliance and validation for the SennosM3 and Sennosystem platforms?”

  • 2

    “With the stated goal of supporting every stage of fluid and fermentation production by 2026, how is Sennos prioritizing its product roadmap and go-to-market efforts across brewing, alternative proteins, biofuels, and pharmaceuticals?”

  • 3

    “Considering the Series B funding and the estimated valuation, what is the company's anticipated timeline for a liquidity event, and how does the current equity structure (including any potential future dilution) impact employee equity value?”

Community

Valuation Sentiment

Our model estimates -37% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.